Adjuvant toripalimab for locally advanced head and neck squamous cell carcinoma patients who achieved pathological complete response after neoadjuvant immunochemotherapy and surgery: A single-arm, phase II trial

被引：0
|
作者：
Chen, S. [1 ]
Yan, S. [1 ]
Hu, W. [2 ]
Lin, Q. [1 ]
Zhou, J. [3 ]
Chen, W. [1 ]
Liu, X. [1 ]
Guo, Z. [1 ]
Zhang, X. [1 ]
Yang, C. [1 ]
Gao, X. [1 ]
Li, M. [1 ]
Li, X. [1 ]
Zhang, S. [1 ]
Zhang, Y. [1 ]
Zhang, Q. [1 ]
Yang, A. [1 ]
Song, M. [1 ]
机构：
[1] Sun Yat Sen Univ Canc Ctr, Dept Head & Neck Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Dept Pathol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ Canc Ctr, Radiol, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.927
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
865P
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [21] Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma (RICE): A Prospective, Single-Arm, Phase II Trial
    Lin, L.
    Li, H.
    Zhao, L.
    Cheng, Y.
    Liu, M. N.
    Fu, X.
    Liu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E464 - E465
  • [22] Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma
    Leidner, Rom
    Crittenden, Marka
    Young, Kristina
    Xiao, Hong
    Wu, Yaping
    Couey, Marcus A.
    Patel, Ashish A.
    Cheng, Allen C.
    Watters, Amber L.
    Bifulco, Carlo
    Morris, George
    Rushforth, Lessli
    Nemeth, Shorin
    Urba, Walter J.
    Gough, Michael
    Bell, R. Bryan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)
  • [23] Induction therapy of toripalimab combined with docetaxel and cisplatin in locally advanced hypopharyngeal squamous cell carcinoma (HPSCC): A single-arm, phase II clinical trial.
    Bai, Chunmei
    Wang, Chenyu
    Jia, Ning
    Chen, Xingming
    Zhu, Xiaoli
    Sun, Shuai
    Shi, Xiaohua
    Chen, Yu
    Luo, Yaping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] A Phase II Trial of Adjuvant Cetuximab and Radiation Therapy in Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Kreinbrink, P. J.
    Mierzwa, M. L.
    Redmond, K. P.
    Wise-Draper, T.
    Casper, K.
    Takiar, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E800 - E800
  • [25] Toripalimab plus Chemotherapy and Radiotherapy for Treatment-Naive, Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Trial
    Wang, Q.
    Wu, L.
    Liang, L.
    Wang, Y.
    Peng, L.
    Han, Y.
    Li, T.
    Lang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E495 - E495
  • [26] Neoadjuvant trial with toripalimab, albumin paclitaxel, and cisplatin on pathological response in locally advanced resectable oral squamous cell carcinoma (Illuminate Trial).
    Zhong, Lai-Ping
    Huang, Ying-Ying
    Sun, Jing-Jing
    Li, Jun
    Dong, Min-Jun
    Zhu, Guopei
    Li, Jiang
    Ju, Wu-Tong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18067 - E18067
  • [27] Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
    Maguire, Patrick D.
    Neal, Charles R.
    Hardy, Stuart M.
    Schreiber, Andrew M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1210 - 1216
  • [28] The impact of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced squamous cell carcinoma of esophagus
    Lin, Jing-Wei
    Hsu, Chung-Ping
    Yeh, Hui-Ling
    Chuang, Cheng-Yen
    Lin, Chih-Hung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (01) : 18 - 24
  • [29] Clinical/biomarker data for neoadjuvant tislelizumab (TIS) plus chemotherapy (Chemo) in resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A single-arm, phase II trial
    Li, Q.
    Cai, L.
    Kuang, D.
    Pan, C.
    Zhao, J.
    Huang, P.
    He, C.
    Xu, K.
    Liu, D.
    Long, G.
    Liu, Z.
    Hu, G.
    Lu, X.
    ANNALS OF ONCOLOGY, 2024, 35 : S621 - S622
  • [30] Pathological Response and Survival Outcome after Neoadjuvant Chemoradiotherapy vs. Immunochemotherapy for Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
    Cheng, S.
    Wu, Y.
    Jianing, W.
    Zhao, Q.
    Zhou, Z. G.
    Liu, Y.
    Fan, B.
    Wang, Y.
    Wang, J.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E492 - E493
12345